Therefore, we set out to investigate CCN2 protein expression by immunohistochemical staining in a large cohort of 75 BM biopsies (55 MPN patients and 20 normal controls) and correlated the results with the amount of BM fibrosis and other disease parameters. The gene discussed is CCN2; the disease is myeloproliferative neoplasm.